论文部分内容阅读
目的对比分析左旋氨氯地平与氨氯地平、硝苯地平、非洛地平在治疗原发性高血压患者时,所致不良反应情况。方法选取我院收治的120例原发性高血压患者为研究对象,将其随机分为A、B、C、D四组,分别给予氨氯地平、硝苯地平、非洛地平及左旋氨氯地平治疗,对比并评价这四组患者的不良反应情况。结果经治疗,D组患者的不良反应率显著低于其他三组,数据差异具有统计学意义(P<0.05)。结论氨氯地平、硝苯地平、非洛地平及左旋氨氯地平为钙离子拮抗剂,均可起到一定的降压效果,但与其他三种药物相比,左旋氨氯地平所致不良反应少,安全性更高,具有重要的临床应用价值。
Objective To compare and analyze the adverse reactions caused by levamlodipine and amlodipine, nifedipine and felodipine in the treatment of patients with essential hypertension. Methods A total of 120 essential hypertension patients admitted to our hospital were selected as study subjects. They were randomly divided into four groups: A, B, C, and D. Amlodipine, nifedipine, felodipine and levamlodine Horizon treatment, contrast and evaluation of adverse reactions in these four groups of patients. Results After treatment, the adverse reaction rate of patients in group D was significantly lower than that of the other three groups (P <0.05). Conclusions Amlodipine, nifedipine, felodipine and levamlodipine are calcium antagonists, all of which may play a certain antihypertensive effect, but compared with the other three drugs, levamlodipine caused adverse reactions Less, more secure, with important clinical value.